We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- Updated knowledge on the immune response to SARS-COV-2
- Antibody tests and their future role
- Current knowledge on how the lungs are being affected during infection
- A hypothesis on why age ranges respond differently to infection
- Animal models to study SARS-COV-2 infection
Biography
Paul Klenerman trained in medicine at Cambridge and Oxford and specialised in infectious diseases. He did his PhD in viral immunology at Oxford University and a postdoc in Zurich before returning to Oxford to establish a lab looking at immune responses to infection. The work includes studies of hepatitis C and a range of viruses affecting the lungs and liver - looking at how these evade the immune response, and the development of vaccines. He is focused especially on novel T cell responses in the mucosal surfaces which are critical for early host defence. He is an NIHR senior fellow and a Wellcome Trust investigator and holds a chair in the Nuffield Department of Medicine in Oxford.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Klenerman, P. (2020, April 27). The immune system response to the SARS-CoV-2 virus: an update [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 5, 2023, from https://hstalks.com/bs/4269/.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Please wait while the transcript is being prepared...
0:00
Interviewer: Hello Professor Klenerman,
thank you for taking the time to do this
update interview after your last
interview recorded with us last month.
What are some of the key
points of knowledge that
we now know about how the immune system
responds to the SARS-CoV-2 virus?
Prof. Klenerman: Lots of
work has been done, and
things are emerging in the literature
often in pre-print format (so they haven't
been formally peer-reviewed), but you get
a glimpse of what people are thinking.
I think the biggest change since we first
spoke has been the development of antibody
tests, I know these have been in the news
a lot with some doom and gloom about them,
but underneath all that there's
been a massive amount of progress.
The development of an antibody
test tells you a couple of things.
One is: what is the quality of the
antibody response against this virus and
how does that relate to disease and
protection?
The other is more general: who has been
exposed to this virus, how far it has
spread through the community and
if you've set up the right sort of study.
The first thing that happened, and it all
happened very fast, was the development of
these lateral-flow assays, or
stick tests, that have been tested.
The problem with those is that although
they are reasonably specific for
whether you have or haven't had COVID-19,
they're not very sensitive,
and not really good enough generally
to be used for diagnostic purposes.
If you are positive on one of those, it's
pretty likely you have been exposed to
the virus, but if you're negative,
you could well have been exposed and
it just misses that, so
the sensitivity is not fantastically high.
The only reason we know that is because
there are much better tests that work in